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Previewshypothesized allosteric change occurs as
a result of assembly into a multi-protein
complex. Furthermore, the use of flex-
ible-fitting of a homology model, de-
scribed below, makes it clear that the
protein subunits at the ends of this
spindle-shaped complex do not undergo
the activating conformational change
that occurs for internal subunits.
Taking the work even further, Scho¨-
negge et al. (2012) used a homology
model of HsTPP II, based on the X-ray
structure of the enzymatically inactive
form of the Drosophila TPP II dimer
(Chuang et al., 2010; Trabuco et al.,
2008), to generate atomistic hypotheses
about the structure and function of
HsTPP II. The homology model was first
docked as a rigid body into the EM
density map. Steric clashes were then
resolved, and the atomic model was
morphed to optimally fit the 3D density
map by using molecular mechanics flex-
ible fitting (Trabuco et al., 2008), thereby566 Structure 20, April 4, 2012 ª2012 Elsevieproducing the final, pseudo-atomic
model. Among the new hypotheses
generated when analyzing this atomic
model, the authors identify possible
changes in conformation, including a rear-
rangement of the active site, removal of
a loop that otherwise blocks the active
site and a shift of helix H6 that is stabilized
by interaction with loop L3 of the adjacent
subunit.
The paper by Scho¨negge et al. (2012) is
a superb example of how sub-nanometer
(‘‘intermediate’’) resolution density maps
obtained by cryo-EM can be combined
with high-resolution X-ray structures,
bioinformatics, and molecular dynamics
to produce informative, pseudo-atomic
models of large (multi-protein) com-
plexes. Such models provide structural
insights that could not be obtained by
any one of these techniques alone. From
a technological point of view, this paper
thus represents an excellent example of
the ‘‘hybrid methods’’ approach that isr Ltd All rights reservedgrowing in power and utility and is taking
an ever more central role in structural
biochemistry and cell biology.REFERENCES
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In this issue of Structure, Das et al. report the structure of the helix-hairpin-helix dimerization domain of XPF
bound to ssDNA. These results provide insight into the architecture of nucleotide excision repair machinery
and how it interacts with damaged DNA substrates.Exposure to natural radiation and indus-
trial pollutants present in our environment
damages DNA. Left unresolved, DNA
damage can lead to genomic instability
and disease. In response, cells have
developed an arsenal of DNA repair
pathways to identify and eliminate
DNA damage. Nucleotide excision repair
(NER) is the primary mechanism em-
ployed by both prokaryotic and eukary-
otic cells to identify and remove
bulky chemical modifications in DNA.
In humans, defects in NER result in
Xerodermapigmentosum (XP),aspectrum
of disorders characterized by extremesensitivity to UV radiation and an approxi-
mately 1,000-fold increase in the develop-
ment of skin cancers. Additionally, the
most severe XP patients display neurode-
generation and dramatically reduced life-
span, underscoring the critical role NER
plays in human health (reviewed in
Nouspikel [2009]).
NER is a multi-step process that occurs
in four phases: (1) damage recognition, (2)
unwinding of the DNA and lesion verifica-
tion, (3) dual incision, and (4) gap-filling
synthesis and ligation. In humans, NER
requires the coordinated activity of over
30 proteins that, together, constitute thedynamic machinery that repairs the
damage. Biochemical studies have re-
vealed NER proceeds as an orchestrated
series of events involving a complicated
network of protein-protein and protein-
DNA interactions (Riedl et al., 2003).
However, a dearth of structural knowl-
edge significantly limits our under-
standing of the molecular mechanisms
of this versatile repair machinery. Human
NER proteins have proven particularly
resistant to structural characterization,
and a lack of conservation between
prokaryotic and eukaryotic NER proteins
limits translation of mechanistic insight
Figure 1. Two Models for the Pre-Incision Complex of Human NER Arising from Uncertainty
in the XPA Binding Site
(A) XPA bound to the 50 ssDNA/dsDNA junction in the NER bubble. In this model, the binding of XPF-
ERCC1 to the 50 junction requires displacement of XPA.
(B) XPA bound to the 30 junction in the NER bubble. In this model, binding of XPA to the 30 junction allows
XPF-ERCC1 full access to the 50 ssDNA/dsDNA substrate. This model is supported by reports indicating
the XPG nuclease binds primarily to dsDNA just downstream of the 30 ssDNA/dsDNA junction.
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Previewsfrom bacterial systems where NER is
better characterized.
Each step in the NERprocess ismarked
by changes in the structure of the DNA
substrate and remodeling of the repair
machinery. Prior to the excision phase,
a region of approximately 30 basepairs
of DNA surrounding the lesion is
unwound, generating an intermediate
known as the pre-incision bubble (Riedl
et al., 2003). XPF and XPG are structure-
specific nucleases, and their positioning
on the DNA substrate is imperative for
their proper function. The XPF-ERCC1
complex is the final repair factor loaded
onto the DNA substrate, and cleavage at
the 50 junction by XPF is required for the
subsequent 30 cleavage event by XPG
(Staresincic et al., 2009). Even though
a substantial amount of structural infor-
mation has accumulated for XPF-ERCC1
(Newman et al., 2005; Tripsianes et al.,
2005, 2007; Tsodikov et al., 2005, 2007),
exactly how it engages DNA and the
molecular basis for the polarity of XPF/
ERCC1 binding to the NER bubble remain
unknown. In this issue of Structure, Das
et al. (2012) report the structure of the
C-terminal dimerization domain of XPF in
complex with ssDNA, which provides
the basis for a refined model of how
and where XPF-ERCC1 binds the NER
bubble.
Although structures of various XPF and
ERCC1 domains have been reported,
insight into how the complex interacts
with DNA has been limited. The three-
dimensional structures of crenarcheal
XPF in the absence and presence of
DNA have been determined; however,
this protein lacks an analog to ERCC1and functions as a homodimer (Newman
et al., 2005). Models proposed for
XPF-ERCC1 binding to the NER bubble
were based on the available structures,
homology to other proteins that bind
DNA with helical hairpins (Singh et al.,
2002), reports showing that both ssDNA
and dsDNA bind to ERCC1 in the XPF-
ERCC1 heterodimer (Tripsianes et al.,
2005, 2007; Tsodikov et al., 2005), and
an NMR chemical shift perturbation study
that mapped the binding site for dsDNA to
the two helical hairpins of ERCC1 in the
XPF-ERCC1 complex (Tripsianes et al.,
2005). However, these previous models
were limited by the absence of explicit
information on ssDNA binding to XPF-
ERCC1.
A key finding in the new structure
described by Das et al. (2012) was that
a one residue deletion in the non-canon-
ical HhH motif in XPF alters the DNA
binding such that ssDNA is preferred
over the dsDNA binding typical of canon-
ical HhH domains (Shao and Grishin,
2000). This is an excellent example of
the powerful effect that very subtle struc-
tural effects can have on biochemical
function. The fact that this change is due
to such a small alteration in sequence
highlights the importance of determining
structures for discerning mechanism.
Most importantly, the structure provides
a direct explanation for how XPF/ERCC1
binds at ssDNA/dsDNA junctions. This
led directly to a model that explains the
polarity of binding and, therefore, why
XPF is directed to the 50 junction.
Whereas the authors’ structural model
for XPF-ERCC1 binding the 50 ssDNA/
dsDNA junction is compelling, it also rai-Structure 20, April 4, 2012ses a number of questions about the
global architecture of the multi-protein
NER complex that assembles on the
pre-incision bubble. Replication protein
A (RPA) is known to play a critical role
in organizing assembly of the NER
machinery and coordinating access to
the DNA substrate (Riedl et al., 2003).
In vitro NER studies have demonstrated
that 30 nucleotides of ssDNA are liber-
ated by dual excision (Moggs et al.,
1996). This corresponds to the approxi-
mate footprint of a single RPA molecule
bound to the unmodified strand opposite
the lesion. In the authors’ model, the
binding of XPF to ssDNA on the undam-
aged strand could lead to a clash with
RPA (Figure 1), which binds ssDNA
much more tightly than XPF-ERCC1 and
remains associated with the unmodified
strand through the transition to gap-filling
synthesis (Riedl et al., 2003). Therefore,
it remains to be determined how binding
of XPF-ERCC1 to the 50 junction influ-
ences the binding of RPA to the template
strand.
On the other hand, the authors’ conclu-
sion that XPF-ERCC1 binds to the 50 junc-
tion has important implications for the
positioning of XPA in the pre-incision
bubble. XPA binds to ssDNA/dsDNA junc-
tions, but it is has yet to be determined
which junction XPA binds in the pre-inci-
sion bubble (Krasikova et al., 2010).
Because XPA is believed to recruit XPF-
ERCC1 to the NER machinery via interac-
tion with the central domain of ERCC1
(Tsodikov et al., 2007), it has been
proposed that XPA binds to the 50 junc-
tion. However, in the authors’ model,
XPF-ERCC1 occludes the entire junction.
If XPA were bound to the 50 junction, XPF-
ERCC1 would have to displace XPA from
the DNA to gain access to the substrate
(Figure 1A). This seems unlikely, as
XPA remains associated with the NER
machinery throughout excision repair
(Riedl et al., 2003). Therefore, XPA must
bind the 30 junction of the NER bubble
(Figure 1B). As the XPG nuclease binds
primarily to the dsDNAbeyond the 30 junc-
tion (Hohl et al., 2003), there would be no
direct competition between XPA and XPG
for binding to the substrate.
Although the human NER proteins have
proven extremely difficult to characterize
structurally, they are slowly revealing their
secrets. The model of XPF-ERCC1 bound
to the 50 bubble junction represents theª2012 Elsevier Ltd All rights reserved 567
Structure
Previewsculmination of multiple structural studies
and provides a fresh perspective on
a critical complex in the NER process.
The proposed model also highlights the
critical requirement to study full-length
proteins and multi-protein complexes to
understand how the evolving architecture
of the NER machine, and the resulting
structural changes induced in the DNA
substrate, drive the progression of bio-
chemical steps required for repair.ACKNOWLEDGMENTS
Research on NER in our laboratory is supported by
the National Institutes of Health (Grants R01
ES1065561, P01 CA92584, P30 CA68485, and
P30 ES00267) and a postdoctoral fellowship from
the American Cancer Society (Grant PF-11-271-
01-DMC). We are grateful to Rachel C. Wright for
preparation of the figure.568 Structure 20, April 4, 2012 ª2012 ElsevieREFERENCES
Das, D., Folkers, G.E., van Dijk, M., Jaspers,
N.G.J., Hoeijmakers, J.H.J., Kaptein, R., and
Boelens, R. (2012). Structure 20, this issue,
667–675.
Hohl, M., Thorel, F., Clarkson, S.G., and Scha¨rer,
O.D. (2003). J. Biol. Chem. 278, 19500–19508.
Krasikova, Y.S., Rechkunova, N.I., Maltseva, E.A.,
Petruseva, I.O., and Lavrik, O.I. (2010). Nucleic
Acids Res. 38, 8083–8094.
Moggs, J.G., Yarema, K.J., Essigmann, J.M., and
Wood, R.D. (1996). J. Biol. Chem. 271, 7177–7186.
Newman, M., Murray-Rust, J., Lally, J., Rudolf, J.,
Fadden, A., Knowles, P.P., White, M.F., and
McDonald, N.Q. (2005). EMBO J. 24, 895–905.
Nouspikel, T. (2009). Cell. Mol. Life Sci. 66,
994–1009.
Riedl, T., Hanaoka, F., and Egly, J.M. (2003).
EMBO J. 22, 5293–5303.
Shao, X., and Grishin, N.V. (2000). Nucleic Acids
Res. 28, 2643–2650.r Ltd All rights reservedSingh, S., Folkers, G.E., Bonvin, A.M., Boelens, R.,
Wechselberger, R., Niztayev, A., and Kaptein, R.
(2002). EMBO J. 21, 6257–6266.
Staresincic, L., Fagbemi, A.F., Enzlin, J.H., Gour-
din, A.M., Wijgers, N., Dunand-Sauthier, I., Giglia-
Mari, G., Clarkson, S.G., Vermeulen, W., and
Scha¨rer, O.D. (2009). EMBO J. 28, 1111–1120.
Tripsianes, K., Folkers, G., Ab, E., Das, D., Odijk,
H., Jaspers, N.G., Hoeijmakers, J.H., Kaptein, R.,
and Boelens, R. (2005). Structure 13, 1849–1858.
Tripsianes, K., Folkers, G.E., Zheng, C., Das, D.,
Grinstead, J.S., Kaptein, R., and Boelens, R.
(2007). Nucleic Acids Res. 35, 5789–5798.
Tsodikov, O.V., Enzlin, J.H., Scha¨rer, O.D., and
Ellenberger, T. (2005). Proc. Natl. Acad. Sci. USA
102, 11236–11241.
Tsodikov, O.V., Ivanov, D., Orelli, B., Staresincic,
L., Shoshani, I., Oberman, R., Scha¨rer, O.D.,
Wagner, G., and Ellenberger, T. (2007). EMBO J.
26, 4768–4776.Discoidin DiscoveriesKathryn M. Ferguson1,*
1Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
*Correspondence: ferguso2@mail.med.upenn.edu
DOI 10.1016/j.str.2012.03.003
In this issue of Structure, Carafoli et al. investigate the mode of antibody-mediated inhibition of the discoidin
domain receptor 1 (DDR1). These studies also provide new insight into activation of the DDRs, which are
unique among receptor tyrosine kinases in the composition of their extracellular regions.Like many receptor tyrosine kinases
(RTKs) the two members of the discoidin
domain receptor family (DDR1 and
DDR2) regulate fundamental cellular
process such as proliferation, differen-
tiation and adhesion (Leitinger, 2011;
Lemmon and Schlessinger, 2010). Dysre-
gulation of these receptors is linked to
a number of human diseases, including
fibrotic disorders, atherosclerosis, and
cancer. Mounting evidence suggests
that DDRs are relevant therapeutic targets
(Valiathan et al., 2012). Inhibitory anti-
bodies, such as those described by Cara-
foli et al. (2012) in this issue of Structure,
will be critical in evaluating the potential
of DDR inhibition in disease settings.
DDRs are unusual RTKs in several
respects. DDR activators—extracellularmatrix collagens in their native triple-helical
conformation—are unique among RTK
ligands. Short triple-helical collagen-
derived peptides are sufficient to activate
DDRs, suggesting that receptor clustering
induced by collagen may not be an essen-
tial aspect of DDR activation. It is believed
that DDRs exist as preformed dimers in
cells and that collagen binding activates
signaling by altering the conformation of
these dimers, rather than by inducing
receptor oligomerization as seen for many
RTKs (Lemmon and Schlessinger, 2010).
The intracellular events following collagen-
inducedDDR activation are broadly similar
to those with other RTKs. The recep-
tors undergo autophosphorylation, recruit
signaling adaptors (including Shc and
Nck), and activate downstream signalingcascades including the mitogen-activated
protein kinase pathway. However, the
timing of these events is unusually slow
and sustained. Exactly how this relates to
signaling outcome is unclear.
A further unusual feature of DDRs is the
unique domain composition of the extra-
cellular region, of which Carafoli et al.
(2012) present the most complete picture
to date. They describe the X-ray crystal
structure of the DDR1 extracellular region
(ECR) lacking only the z50 amino acid,
presumed unstructured, juxtamembrane
(JM) region. The ECR of DDR1 contains
two discoidin (DS) domains, members of
the coagulation factor V/VIII type C super-
family. No other RTK contains extracel-
lular DS domains, but these domains are
found in a number of other proteins
